Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders

Haematologica. 2015 Apr;100(4):e152-4. doi: 10.3324/haematol.2014.116780. Epub 2014 Dec 19.

¹ Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
² Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
³ Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁴ Department for Health Evidence, Biostatistics, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of Haematology, Belfast City Hospital, Belfast, UK.
⁶ Molecular Malignancy Laboratory and Department of Histopathology, Addenbrooke's Hospital-Cambridge University Hospitals, Cambridge, UK.
⁷ Department of Haematology, Addenbrooke's Hospital-Cambridge University Hospitals, Cambridge, UK.
⁸ Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands Patricia.Groenen@radboudumc.nl.

No abstract available

Keywords: Epstein-Barr virus; IG-clonality; immunodeficiency; lymphoproliferative disorders; mortality; predictor.

Publication types